摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-[2-(2-Chloro-phenyl)-1-phenyl-ethyl]-piperazine | 860351-63-9

中文名称
——
中文别名
——
英文名称
1-[2-(2-Chloro-phenyl)-1-phenyl-ethyl]-piperazine
英文别名
1-(2-(2-Chlorophenyl)-1-phenylethyl)piperazine;1-[2-(2-chlorophenyl)-1-phenylethyl]piperazine
1-[2-(2-Chloro-phenyl)-1-phenyl-ethyl]-piperazine化学式
CAS
860351-63-9
化学式
C18H21ClN2
mdl
——
分子量
300.831
InChiKey
SDLVJPBOBLQFEW-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.7
  • 重原子数:
    21
  • 可旋转键数:
    4
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    15.3
  • 氢给体数:
    1
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • [EN] PIPERAZINE DERIVATIVES WHICH EXHIBIT ACTIVITY AS SEROTONIN AND NORADRENALINE RE-UPATKE INHIBITORS<br/>[FR] DERIVES DE LA PIPERAZINE PRESENTANT UNE ACTIVITE EN TANT QU'INHIBITEURS DU RECAPTAGE DE LA SEROTONINE ET DE LA NORADRENALINE
    申请人:PFIZER LTD
    公开号:WO2005068447A1
    公开(公告)日:2005-07-28
    A compound of formula (I), wherein R1 is H; R2 is aryl, het, C3-8cycloalkyl, C1-6alkyl, (CH2)zaryl or R4, wherein each of the cycloalkyl, aryl, het and R4 groups is optionally substituted by at least one substituent independently selected from C1-6alkyl, C1-6alkoxy, OH, halo, CF3, OCF3, OCHF2, O(CH2)yCF3, CN, CONH2, CON(H)C1-6alkyl, CON(C1-6alkyl)2, hydroxy-C1-6alkyl, Cl-4alkoxy-C1-6alkyl, C1-4alkoxy-C1-4alkoxy, SCF3, C1-6alkyISO2, C1-4alkyl-S-Cl-4alkyl, C1-4alkyl-S-, C1-4alkyINR10R11 and NR10R11; or R1 and R2, together with the carbon atom to which they are bound, form a 5- or 6-membered carbocycle or a 5- or 6-membered heterocycle containing at least one N, O or S heteroatom; R3 is aryl, het or R4, each optionally substituted by at least one substituent independently selected from C1-6alkyl, C1-6alkoxy, het, OH, halo, CF3, OCF3, OCHF2, O(CH2)yCF3, CN, CONH2, CON(H)C1-6alkyl, CON(C1-6alkyl)2, hydroxy-Cl-6alkyl, C1-4alkoxy-C1-6alkyl, C1-4alkoxy-C1-4 alkoxy, SCF3, C1-6alkyISO2, C1-4alkyl-S-C1-4alkyl, C1-4alkyl-S-, C1-4 alkylNR10R11and NR10R11; R4 is a phenyl group fused to a 5- or 6­ membered carbocycle, or a phenyl group fused to a 5- or 6-membered heterocycle containing at least one N, O or S heteroatom; R5 is H or C1- 6alkyl; R10 and R11 are the same or different and are independently H or C1-4alkyl; A is a C1-3alkylene chain which is optionally substituted by OH, C1-4alkyl or C1-4alkoxy; x is an integer from 1 to 3; y is 1 or 2; z is an integer from 1 to 3; aryl is phenyl, naphthyl, anthracyl or phenanthryl; and het is an aromatic or non-aromatic 4-, 5- or 6-membered heterocycle which contains at least one N, O or S heteroatom, optionally fused to a 5- ­or 6-membered carbocycle or a second 4-, 5- or 6-membered heterocycle which contains at least one N, O or S heteroatom.
    式(I)的化合物,其中R1为H;R2为芳基,杂环基,C3-8环烷基,C1-6烷基,(CH2)z芳基或R4,其中每个环烷基,芳基,杂环基和R4基团可以选择地被至少一个取自C1-6烷基,C1-6甲氧基,OH,卤素,CF3,O ,OCHF2,O( )y ,CN,CONH2,CON(H)C1-6烷基,CON(C1-6烷基)2,羟基-C1-6烷基,Cl-4烷氧基-C1-6烷基,C1-4烷氧基-C1-4烷氧基,S ,C1-6烷基ISO2,C1-4烷基-S-Cl-4烷基,C1-4烷基-S-,C1-4烷基NR10R11和NR10R11;或者R1和R2,连同它们结合的碳原子,形成一个含有至少一个N,O或S杂原子的5-或6元碳环或5-或6元杂环;R3为芳基,杂环基或R4,每个可以选择地被至少一个取自C1-6烷基,C1-6甲氧基,杂环基,OH,卤素, ,O ,OCHF2,O( )y ,CN,CONH2,CON(H)C1-6烷基,CON(C1-6烷基)2,羟基-C1-6烷基,C1-4烷氧基-C1-6烷基,C1-4烷氧基-C1-4烷氧基,S ,C1-6烷基ISO2,C1-4烷基-S-C1-4烷基,C1-4烷基-S-,C1-4烷基NR10R11和NR10R11;R4为与一个含有至少一个N,O或S杂原子的5-或6元碳环融合的苯基,或者与一个含有至少一个N,O或S杂原子的5-或6元杂环融合的苯基;R5为H或C1-6烷基;R10和R11相同或不同且独立地为H或C1-4烷基;A为C1-3烷基链,可以选择地被OH,C1-4烷基或C1-4甲氧基取代;x为1到3的整数;y为1或2;z为1到3的整数;芳基为苯基,基,基或基;杂环基为含有至少一个N,O或S杂原子的芳香或非芳香4-,5-或6元杂环,可以选择地与一个含有至少一个N,O或S杂原子的5-或6元碳环或第二个含有至少一个N,O或S杂原子的4-,5-或6元杂环融合。
  • Piperazine derivatives which exhibit activity as serotonin and noradrenaline re-uptake inhibitors
    申请人:Bish Gerwyn
    公开号:US20070105870A1
    公开(公告)日:2007-05-10
    A compound of formula (I), wherein R 1 is H; R 2 is aryl, het, C 3-8 cycloalkyl, C 1-6 alkyl, (CH 2 ) 2 aryl or R 4 , wherein each of the cycloalkyl, aryl, het and R 4 groups is optionally substituted by at least one substituent independently selected from C 1-6 alkyl, C 1-6 alkoxy, OH, halo, CF 3 , OCF 3 , OCHF 2 , O(CH 2 ) y CF 3 , CN, CONH 2 , CON(H)C 1-6 alkyl, CON(C 1-6 alkyl) 2 , hydroxy-C 1-6 alkyl, C 1-4 alkoxy-C 1-6 alkyl, C 1-4 alkoxy-C 1-4 alkoxy, SCF 3 , C 1-6 alkyISO 2 , C 1-4 alkyl-S-C 1-4 alkyl, C 1-4 alkyl-S—, C 1-4 alkyINR 10 R 11 and NR 10 R 11 ; or R 1 and R 2 , together with the carbon atom to which they are bound, form a 5- or 6-membered carbocycle or a 5- or 6-membered heterocycle containing at least one N, O or S heteroatom; R 3 is aryl, het or R 4 , each optionally substituted by at least one substituent independently selected from C 1-6 -alkyl, C 1-6 -alkoxy, het, OH, halo, CF 3 , OCF 3 , OCHF 2 , O(CH 2 ) y CF 3 , CN, CONH 2 , CON(H)C 1-6 alkyl, CON(C 1-6 alkyl) 2 , hydroxy-C 1-6 alkyl, C 1-4 alkoxy-C 1-6 alkyl, C 1-4 alkoxy-C 1-4 alkoxy, SCF 3 , C 1-6 alkyISO 2 , C 1-4 alkyl-S-C 1-4 alkyl, C 1-4 alkyl-S—, C 1-4 alkylNR 10 R 11 and NR 10 R 11 ; R 4 is a phenyl group fused to a 5- or 6 membered carbocycle, or a phenyl group fused to a 5- or 6-membered heterocycle containing at least one N, O or S heteroatom; R 5 is H or C 1-6 alkyl; R 10 and R 11 are the same or different and are independently H or C 1-4 alkyl; A is a C 1-3 alkylene chain which is optionally substituted by OH, C 1-4 alkyl or C 1-4 alkoxy; x is an integer from 1 to 3; y is 1 or 2; z is an integer from 1 to 3; aryl is phenyl, naphthyl, anthracyl or phenanthryl; and het is an aromatic or non-aromatic 4, 5- or 6-membered heterocycle which contains at least one N, O or S heteroatom, optionally fused to a 5- or 6-membered carbocycle or a second 4, 5- or 6-membered heterocycle which contains at least one N, O or S heteroatom.
    化合物的化学式为(I),其中R1为H; R2为芳基,杂环,C3-8环烷基,C1-6烷基,(CH2)2芳基或R4,其中环烷基,芳基,杂环和R4基团中的每一个都可以独立地被至少一个取代基取代,所述取代基从C1-6烷基,C1-6烷氧基,OH,卤素,CF3,O ,OCHF2,O( )y ,CN,CONH2,CON(H)C1-6烷基,CON(C1-6烷基)2,羟基-C1-6烷基,C1-4烷氧基-C1-6烷基,C1-4烷氧基-C1-4烷氧基,S ,C1-6烷基ISO2,C1-4烷基-S-C1-4烷基,C1-4烷基-S-,C1-4烷基INR10R11和NR10R11中独立选择; 或者R1和R2与它们所连接的碳原子一起形成一个含有至少一个N,O或S杂原子的5-或6-成员碳环或5-或6-成员杂环; R3为芳基,杂环或R4,每个都可以独立地被至少一个取代基取代,所述取代基从C1-6烷基,C1-6烷氧基,杂环,OH,卤素, ,O ,OCHF2,O( )y ,CN,CONH2,CON(H)C1-6烷基,CON(C1-6烷基)2,羟基-C1-6烷基,C1-4烷氧基-C1-6烷基,C1-4烷氧基-C1-4烷氧基,S ,C1-6烷基ISO2,C1-4烷基-S-C1-4烷基,C1-4烷基-S-,C1-4烷基NR10R11和NR10R11中独立选择; R4是融合到5-或6-成员碳环中的苯基或融合到至少一个N,O或S杂原子的5-或6-成员杂环中的苯基; R5为H或C1-6烷基; R10和R11相同或不同,独立地为H或C1-4烷基; A为C1-3烷基链,可以选择地被OH,C1-4烷基或C1-4烷氧基取代; x为1到3的整数; y为1或2; z为1到3的整数; 芳基为苯基,基,基或基; 杂环为含有至少一个N,O或S杂原子的芳香或非芳香4、5-或6-成员杂环,可以选择地融合到一个5-或6-成员碳环或第二个含有至少一个N,O或S杂原子的4、5-或6-成员杂环中。
查看更多

同类化合物

(E,Z)-他莫昔芬N-β-D-葡糖醛酸 (E/Z)-他莫昔芬-d5 (4S,5R)-4,5-二苯基-1,2,3-恶噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S,5R,5''R)-2,2''-(1-甲基亚乙基)双[4,5-二氢-4,5-二苯基恶唑] (4R,5S)-4,5-二苯基-1,2,3-恶噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4R,4''R,5S,5''S)-2,2''-(1-甲基亚乙基)双[4,5-二氢-4,5-二苯基恶唑] (1R,2R)-2-(二苯基膦基)-1,2-二苯基乙胺 鼓槌石斛素 黄子囊素 高黄绿酸 顺式白藜芦醇三甲醚 顺式白藜芦醇 顺式己烯雌酚 顺式-白藜芦醇3-O-beta-D-葡糖苷酸 顺式-桑皮苷A 顺式-曲札芪苷 顺式-二苯乙烯 顺式-beta-羟基他莫昔芬 顺式-a-羟基他莫昔芬 顺式-3,4',5-三甲氧基-3'-羟基二苯乙烯 顺式-1-(3-甲基-2-萘基)-2-(2-萘基)乙烯 顺式-1,2-双(三甲基硅氧基)-1,2-双(4-溴苯基)环丙烷 顺式-1,2-二苯基环丁烷 顺-均二苯乙烯硼酸二乙醇胺酯 顺-4-硝基二苯乙烯 顺-1-异丙基-2,3-二苯基氮丙啶 非洲李(PRUNUSAFRICANA)树皮提取物 阿非昔芬 阿里可拉唑 阿那曲唑二聚体 阿托伐他汀环氧四氢呋喃 阿托伐他汀环氧乙烷杂质 阿托伐他汀环(氟苯基)钠盐杂质 阿托伐他汀环(氟苯基)烯丙基酯 阿托伐他汀杂质D 阿托伐他汀杂质94 阿托伐他汀杂质7 阿托伐他汀杂质5 阿托伐他汀内酰胺钠盐杂质 阿托伐他汀中间体M4 阿奈库碘铵 锌(II)(苯甲醛)(四苯基卟啉) 银松素 铜酸盐(5-),[m-[2-[2-[1-[4-[2-[4-[[4-[[4-[2-[4-[4-[2-[2-(羧基-kO)苯基]二氮烯基-kN1]-4,5-二氢-3-甲基-5-(羰基-kO)-1H-吡唑-1-基]-2-硫代苯基]乙烯基]-3-硫代苯基]氨基]-6-(苯基氨基)-1,3,5-三嗪-2-基]氨基]-2-硫代苯基]乙烯基]-3-硫代 铒(III) 离子载体 I 铀,二(二苯基甲酮)四碘- 钾钠2,2'-[(E)-1,2-乙烯二基]二[5-({4-苯胺基-6-[(2-羟基乙基)氨基]-1,3,5-三嗪-2-基}氨基)苯磺酸酯](1:1:1) 钠{4-[氧代(苯基)乙酰基]苯基}甲烷磺酸酯 钠;[2-甲氧基-5-[2-(3,4,5-三甲氧基苯基)乙基]苯基]硫酸盐 钠4-氨基二苯乙烯-2-磺酸酯